2020年9月30日,财政部、海关总署、税务总局、药监局联合发布《关于发布第二批适用增值税政策的抗癌药品和罕见病药品清单的公告》,39个抗癌药制剂、6个抗癌药原料药以及14个罕见病药品制剂被纳入。
Continue Reading 进出口监管最新动态评析 ——海关、外汇与贸易管制(2020年10月刊)

历经三载春秋磨砺,中国《出口管制法》终于在2020年10月17日经第十三届全国人大常委会第二十二次会议表决通过,将于今年12月1日起正式实施。在当前以“中美贸易战”为代表的国际新形势下,本法的出台受到了中外各界的高度关注。金杜团队自本法被列入立法计划之初就全程跟进并针对历次草案发表过有关解析文章[1]。在此基础上,本文将全面解读本次最终法案的重要制度及主要亮点,向广大中外企业提出合规建议。
Continue Reading 尘埃落定,全面速解中国《出口管制法》

Written by: Jing Yunfeng Li Jia Wang Hui Li Xinyan Corporate&Commercial Group 

Introduction

The revised Catalogue of Technologies Prohibited or Restricted from Export of the PRC (“Catalogue“) was finally issued on August 28, 2020. This is the first revision of the Catalogue since 2008, coinciding with an extremely special period of China-US relations. Therefore, the Catalogue aroused wide attention at home and abroad. We will interpret the adjustments made to the Catalogue in the form of Q&A to assist enterprises in improving their internal control systems for technology export compliance and effectively guarding against relevant legal risks.
Continue Reading Revision of the Catalogue of Technologies Prohibited or Restricted from Export of the PRC